• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

'Glaucoma 360' slated for February

Article

The Glaucoma Research Foundation (GRF) will present Glaucoma 360, a three-day series of events offering a ?full-compass view? of the cure, catalysts, and care of glaucoma, Feb. 2 to 4, 2012, at the Palace Hotel in San Francisco.

San Francisco-The Glaucoma Research Foundation (GRF) will present Glaucoma 360, a 3-day series of events offering a “full-compass view” of the cure, catalysts, and care of glaucoma, Feb. 2 to 4, 2012, at the Palace Hotel in San Francisco.

“Glaucoma 360 promises to bring together a confluence of top-tier glaucoma leaders from the fields of medicine, science, business, investment, philanthropy, and media with those affected by glaucoma. All proceeds will benefit [GRF] and help support research, outreach, and education,” said Andrew Iwach, MD, chairman of GRF’s board of directors, and Adrienne Graves, PhD, a member of GRF’s board of directors. The two are co-chairing the event.

Ophthalmology Times will be the global media sponsor and official publication for Glaucoma 360 events.

“We are proud to welcome the seasoned and experienced team at Ophthalmology Times,” said Thomas M. Brunner, GRF president and chief executive officer, “to ensure that all the important contributions of Glaucoma 360 participants can be shared around the world.”

Glaucoma 360 will include a benefit and awards presentation, the New Horizons forum, and a glaucoma symposium for continued medical education credit. For information on all Glaucoma 360 events, visit www.glaucoma.org.

Related Videos
Paul Badawi, co-founder and CEO of Sight Sciences, chats with Neda Shamie, MD, about what drives him
© 2024 MJH Life Sciences

All rights reserved.